Nasal spray for Alzheimer’s: How a Mass. man is the only one to try it so far
A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
BioSpace1d
Psychedelics Space Regroups as RFK Jr. Signals Support
After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
Nearly 100,000 bottles of nasal spray recalled for 'microbial failure'
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
Medical Design and Outsourcing4d
Nasal vaccine devices: Design and regulatory need-to-knows
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
FDA recalls 90K bottles of nasal spray due to potential ‘adverse’ effects: Throw out ASAP
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
Don’t use this nasal spray: FDA says it may cause ‘adverse’ effects
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
stocknews9d
3 Defensive Stocks to Buy Before the Next Market Crash
Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...
manilatimes11d
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or "TMS”) and Spravato® (esketamine nasal spray) for the treatment of major depressive disorder ("MDD”) and other mental ...
Philippine Daily Inquirer14d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
BioSpace15d
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
News on 615d
FDA expands approval for antidepressant nasal spray
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression.
CBC.ca15d
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health help
But it remains costly — and controversial Health Canada approved a prescription esketamine nasal spray called Spravato in 2020 to help with treatment-resistant depression. Brandi Martin ...